Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6U58

Toho1 Beta Lactamase Glu166Gln Mutant

Summary for 6U58
Entry DOI10.2210/pdb6u58/pdb
DescriptorBeta-lactamase, SULFATE ION (3 entities in total)
Functional Keywordshydrolase
Biological sourceEscherichia coli
Total number of polymer chains1
Total formula weight28295.85
Authors
Langan, P.S.,Sullivan, B.,Weiss, K.L. (deposition date: 2019-08-27, release date: 2020-02-19, Last modification date: 2024-04-03)
Primary citationLangan, P.S.,Sullivan, B.,Weiss, K.L.,Coates, L.
Probing the Role of the Conserved Residue Glu166 in a Class A Beta-Lactamase Using Neutron and X-ray Protein Crystallography
Acta Crystallogr.,Sect.D, 76:118-123, 2020
Cited by
PubMed Abstract: The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.
PubMed: 32038042
DOI: 10.1107/S2059798319016334
PDB entries with the same primary citation
Experimental method
NEUTRON DIFFRACTION (1.89 Å)
X-RAY DIFFRACTION (1.9 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon